TBF
Also known as Thymosin beta-4 fragment, Tbeta4 fragment
A vendor shorthand that usually refers to a thymosin beta-4 fragment; interpretation depends on whether the product is TB-500, full thymosin beta-4, or another fragment.
Overview
TBF is a shorthand product label, not a universally standardized peptide name. In peptide markets it often means "thymosin beta-4 fragment," which may overlap with TB-500 or related fragments.
The Science
Thymosin beta-4 biology centers on actin dynamics, cell migration, angiogenesis, and tissue-repair models.
- Cell migration - a core theme in thymosin beta-4 fragment research.
- Angiogenesis - vascular repair and wound models.
- Repair signaling - soft-tissue and dermal repair claims are common.
Evidence Snapshot
Because "TBF" can be ambiguous, product identity is the main evidence question. If it is TB-500, the TB-500 profile is the relevant starting point.
Related
More in Healing & Recovery
ARA-290
InvestigationalHealing & Recovery
An erythropoietin-derived peptide studied for tissue-protective and anti-inflammatory signaling without the red-blood-cell stimulation associated with EPO.
Botulinum Toxin
FDA-approvedHealing & Recovery
Not a peptideProtein toxin
A bacterial neurotoxin protein used clinically in tightly controlled doses for neuromuscular, migraine, autonomic, and cosmetic indications; it is not a peptide supplement.
BPC-157
Research compoundHealing & Recovery
A stable 15-amino-acid peptide fragment derived from a protein in human gastric juice, widely studied in preclinical models for tissue protection and repair across gut, tendon, muscle, and vascular tissue.